UK rates of gout soaring, but treatment remains poor

January 15, 2014

UK rates of gout have soared since the late1990s, with one in every 40 people now affected by the condition - the highest in Europe - but treatment remains as poor now as it was then, reveals research published online in the Annals of the Rheumatic Diseases.

But there is wide variation in both the prevalence (existing cases) and incidence (new cases) of gout across the UK, with the highest numbers of cases in Wales and the North East of England, the data show.

The researchers used the Clinical Practice Research Datalink (CPRD) to estimate both the prevalence and incidence of gout in the UK between 1997 and 2012.

The CPRD, formerly the General Practice Research Database until it was renamed in 2012, is one of the largest databases of long term primary care medical records in the world, holding those of around 12 million of the UK population.

The researchers also looked at treatment for those who already had gout and those who were newly diagnosed (within six to 12 months) to see how well their condition was being managed.

Among more than 4.5 million eligible people on the database in 2012, almost 116,000 already had gout, giving a prevalence of 2.5%.

Men were significantly more likely to have been diagnosed with the condition than were women, peaking at a ratio of 11:2 between the ages of 35 and 39. Gout was rare among those younger than 20.

More than 7000 new diagnoses of gout were identified, giving an overall incidence of 2.26 per 1000 person years - 3.5 per 1000 person years among men.

The gender gap for diagnosis was at its widest for those aged 30-34, but new cases of gout were highest among those aged 80-84, for both sexes.

Between 1997 and 2012, the prevalence of gout rose by 64%, increasing by around 4% every year. Rates were around four times higher in men across the entire period.

The number of new cases rose by 30% during this time, increasing by around 1.5% each year. Men were around three times as likely to be diagnosed with the condition as women across the entire period.

The patterns of both prevalence and incidence varied widely across the UK, with prevalence highest in the North East of England and Wales, and lowest in Scotland and Northern Ireland.

New diagnoses were lowest in the East of England and Northern Ireland and again highest in Wales and the North East of England.

Only a third of people with were being treated with urate lowering drugs, a percentage that remained constant over the entire period.

In 2012, fewer than one in five patients was prescribed these drugs within six months of their diagnosis, and only around one in four was on this treatment a year after diagnosis - a pattern that remained more or less unchanged since 1997, despite the publication of guidelines on optimal management of the condition.

Patients got better at taking their drugs, with around four out of 10 doing so in 2012, compared with 28% in 1997, but these figures are still not a cause for celebration, say the authors.

Explore further: Dual-energy CT may be useful in evaluating the severity of gout, study suggests

More information: Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study, Online First, DOI: 10.1136/annrheumdis-2013-204463

Related Stories

Dual-energy CT may be useful in evaluating the severity of gout, study suggests

April 30, 2011
The incidence of gout is on the rise and duel energy CT has the potential to allow non-invasive diagnosis of the disease, according to radiologists at the University of British Columbia, Vancouver General Hospital, in Vancouver, ...

Prevalence of gout increases with increasing BMI

July 17, 2012
(HealthDay) -- Having an increased body mass index (BMI) correlates with increased prevalence of gout in adults, according to study published online July 6 in Arthritis Care & Research.

New report shows diagnosed diabetes, pre-diabetes, and gestational diabetes is on the rise among privately insured Ameri

December 16, 2013
About 8.8 percent of the privately insured population in 2012 had diabetes or was diagnosed as being at high risk for diabetes, up from 8.3 percent in 2011, but the rates of disease varied depending on age, gender and region ...

New cases of autism in UK have levelled off after 5-fold surge during 1990s

October 16, 2013
The number of newly diagnosed cases of autism has levelled off in the UK after a five-fold surge during the 1990s, finds research published in the online journal BMJ Open.

New evidence that 'gout' strongly runs in the family

December 2, 2013
It's historically known as 'the king of diseases and the disease of kings' and was long thought to be caused by an overindulgent lifestyle, but now scientists at The University of Nottingham have confirmed that 'gout' strongly ...

The incidence of eating disorders is increasing in the UK

May 20, 2013
More people are being diagnosed with eating disorders every year and the most common type is not either of the two most well known—bulimia or anorexia—but eating disorders not otherwise specified (eating disorders that ...

Recommended for you

Study shows prevalence of knee osteoarthritis has doubled since World War II

August 14, 2017
The average American today is twice as likely to be diagnosed with knee osteoarthritis than in the years before World War II, Harvard scientists say, but that increase can't be blamed on the reasons most might think.

Researchers find arthritis drug could treat blood cancer patients

August 3, 2017
Blood cancer sufferers could be treated with a simple arthritis drug, scientists at the University of Sheffield have discovered.

Fluid in the knee holds clues for why osteoarthritis is more common in females

June 26, 2017
Researchers have more evidence that males and females are different, this time in the fluid that helps protect the cartilage in their knee joints.

Biologics before triple therapy not cost effective for rheumatoid arthritis

May 29, 2017
Stepping up to biologic therapy when methotrexate monotherapy fails offers minimal incremental benefit over using a combination of drugs known as triple therapy, yet incurs large costs for treating rheumatoid arthritis (RA). ...

Drug for refractory psoriatic arthritis shows promise in clinical trial

May 24, 2017
In a pivotal phase-3 clinical trial led by a Stanford University School of Medicine investigator, patients with psoriatic arthritis for whom standard-of-care pharmaceutical treatments have provided no lasting relief experienced ...

Cross-species links identified for osteoarthritis

May 17, 2017
New research from the University of Liverpool, published today in the journal npj Systems Biology and Applications, has identified 'cell messages' that could help identify the early stages of osteoarthritis (OA).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.